Sanofi ADS SNY
HEALTHCARE · DRUG MANUFACTURERS - GENERALi
Market dataready · fetched 2026-11-13T02:49:18.723Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T22:07:15.313187464Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T02:42:15.386653+00:00
Sanofi ADS options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 51.07 | 41.8% | 6.6% | 46.12 | 31.8% | 4.9% |
| 25Δ | 49.93 | 33.2% | 4.3% | 46.60 | 30.1% | 4.0% |
| 30Δ | 49.60 | 33.9% | 4.0% | 47.09 | 28.4% | 3.1% |
| 35Δ | 49.27 | 34.7% | 3.6% | |||
| 40Δ | 48.94 | 35.4% | 3.2% | |||
| 45Δ | 48.61 | 36.1% | 2.9% | |||
| 50Δ | 48.28 | 36.9% | 2.5% | |||
| 55Δ | 47.95 | 37.6% | 2.2% | |||
| 60Δ | 47.62 | 38.3% | 1.8% | |||
| 65Δ | 47.11 | 40.7% | 1.5% | |||
| 70Δ | 46.51 | 44.0% | 1.3% | |||
| 75Δ | 45.91 | 47.3% | 1.1% | |||
| 80Δ | 45.31 | 50.5% | 0.9% | |||
20Δ
- Pseudo strike
- 51.07
- IV
- 41.8%
- B/E move
- 6.6%
- Pseudo strike
- 46.12
- IV
- 31.8%
- B/E move
- 4.9%
25Δ
- Pseudo strike
- 49.93
- IV
- 33.2%
- B/E move
- 4.3%
- Pseudo strike
- 46.60
- IV
- 30.1%
- B/E move
- 4.0%
30Δ
- Pseudo strike
- 49.60
- IV
- 33.9%
- B/E move
- 4.0%
- Pseudo strike
- 47.09
- IV
- 28.4%
- B/E move
- 3.1%
35Δ
- Pseudo strike
- 49.27
- IV
- 34.7%
- B/E move
- 3.6%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 48.94
- IV
- 35.4%
- B/E move
- 3.2%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 48.61
- IV
- 36.1%
- B/E move
- 2.9%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 48.28
- IV
- 36.9%
- B/E move
- 2.5%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 47.95
- IV
- 37.6%
- B/E move
- 2.2%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 47.62
- IV
- 38.3%
- B/E move
- 1.8%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 47.11
- IV
- 40.7%
- B/E move
- 1.5%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 46.51
- IV
- 44.0%
- B/E move
- 1.3%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 45.91
- IV
- 47.3%
- B/E move
- 1.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 45.31
- IV
- 50.5%
- B/E move
- 0.9%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 26.61% | |
| 27.73% | |
| 27.43% | |
| 27.96% | |
| 27.88% | |
| 28.31% | |
| 28.29% | |
| 28.27% | |
| 29.03% | |
| 26.29% |
Drug Manufacturers - General
ABBV
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
More →AMGN
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular…
More →AMRN
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United…
More →AZN
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections,…
More →BIIB
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the…
More →BMY
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and…
More →